Dina Fioretti, a 60-year-old from Illinois, filed a lawsuit against Novo Nordisk, alleging severe side effects from the drug Ozempic. Born on , 1964, Dina Fioretti hails from Illinois, United States. As in 2025, Dina Fioretti's age is 61 years. Check below for more deets about Dina Fioretti. Learn more about Dina Fioretti facts, biography, age, birthday, trivia and more.
Dina Fioretti Profile:
| Stage Name | Dina Fioretti |
| Real Name | Dina Fioretti |
| Profession(s) | |
| Birthday | , 1964 |
| Zodiac Sign | Capricorn |
| Age | 61 years |
| Gender | Female |
| Birthplace | Illinois, United States |
| Hometown | Illinois, Illinois, United States |
| Nationality | American |
Dina Fioretti Family | |
| Father: | Not Available |
| Mother: | Not Available |
| Brother(s): | Not Available |
| Sister(s): | Not Available |
Family and Personal Life
- Dina Fioretti‘ father’s name is Not Available and Dina Fioretti‘ mother’s name is Not Available.
Dina Fioretti Trivia
- Dina Fioretti was born in Illinois, United States.
- Dina Fioretti’s birth sign is Capricorn.
- Lawsuit Origins: Dina Fioretti, a 60-year-old from Illinois, sued Novo Nordisk, claiming severe side effects from the drug Ozempic.
- Adverse Effects: Fioretti’s complaint includes extreme vomiting, pain, and a blocked bowel, resulting in a torn esophagus, also known as a Mallory-Weiss tear.
- Joined Legal Campaign: Fioretti’s case joins a growing legal effort involving thousands of patients claiming similar harrowing experiences with Ozempic.
- Nationwide Litigation: Nearly 60 lawsuits, including Fioretti’s, have been brought against Novo Nordisk by patients suffering from stomach paralysis linked to Ozempic use.
- Severity of Cases: Some cases involve lifelong complications, such as permanent diarrhea, intestinal surgery, and gallbladder removal due to alleged drug side effects.
- Lack of Warning: Patients allege they weren’t adequately warned about the extreme side effects associated with Ozempic use.
- Legal Consolidation: A panel of judges centralized the lawsuits into a multidistrict litigation (MDL) in a Pennsylvania federal court, anticipating up to 10,000 cases.
- Legal Representation: Fioretti’s complaint was filed by the Moll Law Group, one of several firms investigating claims from numerous affected patients.
- Health impact: Fioretti’s ordeal resulted in a week-long hospitalization, requiring medical intervention to address the tear in her throat and alleviate associated symptoms.
- Manufacturer Responsibility: The lawsuit accuses Novo Nordisk of failing to adequately warn consumers about risks like ileus and stomach paralysis associated with Ozempic use.
- Legal Defense: Novo Nordisk and Eli Lilly, the manufacturers of Ozempic and similar drugs, have stated that they intend to vigorously defend against the allegations.
- Litigation Management: US District Judge Gene E Pratter oversees the multidistrict litigation, which includes at least 55 lawsuits against Novo Nordisk and Eli Lilly.
- Scope of Legal Action: Additional cases are being investigated and added to the MDL, with attorneys expecting thousands more claims over time.
- Off-label Use: While Ozempic is FDA-approved for type 2 diabetes, it is frequently prescribed off-label for weight loss, which may increase the number of people affected.
- Marketing Practices: The allegations against Novo Nordisk and Eli Lilly include aggressive marketing strategies for drugs such as Ozempic and Mounjaro.
- Patient Experience: Zakareeya Gregory, another plaintiff in the MDL, reported severe complications, including gallbladder removal, allegedly caused by Ozempic use.
- Personal Impact: Gregory’s ordeal included a four-week hospital stay, gallbladder removal surgery, and ongoing health complications after discontinuing Ozempic use.
- Weight Fluctuation: Gregory regained her lost weight after discontinuing Ozempic and continues to suffer from gallbladder-related issues, which have an impact on her quality of life.
- Legal Strategy: Attorneys leading the cases suggest a pattern of first obtaining FDA approval for diabetes treatment before marketing drugs like Ozempic for weight loss.
- Continued Investigation: Legal proceedings are uncovering additional cases of severe side effects purportedly linked to Ozempic and similar medications, as reported by the Daily Mail.
FAQs
Who is Dina Fioretti?
Dina Fioretti has filed a lawsuit against Novo Nordisk, alleging that the drug Ozempic caused severe side effects.
How old is Dina Fioretti?
Dina Fioretti is 60 years old as of 2024.
Where is Dina Fioretti from?
Dina Fioretti is from Illinois.
What happened to Dina Fioretti?
Dina Fioretti experienced extreme vomiting, pain, and a blocked bowel after using Ozempic, resulting in a torn esophagus and a week-long hospitalization.